Chad Messer
Stock Analyst at Lake Street
(1.13)
# 3,815
Out of 5,116 analysts
30
Total ratings
36.67%
Success rate
-11.7%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Chad Messer
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| IMNM Immunome | Maintains: Buy | $22 → $32 | $24.62 | +29.98% | 2 | Dec 16, 2025 | |
| OSTX OS Therapies | Maintains: Buy | $18 → $17 | $1.36 | +1,150.00% | 2 | Nov 18, 2025 | |
| GNLX Genelux | Initiates: Buy | $16 | $2.66 | +501.50% | 1 | Oct 21, 2025 | |
| MNPR Monopar Therapeutics | Initiates: Buy | $106 | $60.38 | +75.55% | 1 | Sep 23, 2025 | |
| BOLT Bolt Biotherapeutics | Maintains: Buy | $4 → $75 | $5.90 | +1,171.19% | 2 | Aug 15, 2025 | |
| ONCY Oncolytics Biotech | Initiates: Buy | $7 | $0.98 | +613.78% | 1 | Aug 13, 2025 | |
| COYA Coya Therapeutics | Initiates: Buy | $16 | $4.65 | +244.09% | 1 | Jul 9, 2025 | |
| LTRN Lantern Pharma | Initiates: Buy | $25 | $3.15 | +693.65% | 1 | Apr 2, 2025 | |
| ESPR Esperion Therapeutics | Maintains: Strong Buy | $134 → $114 | $3.39 | +3,262.83% | 3 | Aug 3, 2021 | |
| CELC Celcuity | Initiates: Buy | $50 | $109.42 | -54.30% | 1 | Jul 27, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $48 | $63.19 | -24.04% | 2 | Jul 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 → $30 | $41.36 | -27.47% | 3 | Jun 28, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $50 | $72.57 | -31.10% | 1 | Jun 17, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $31 → $29 | $7.76 | +273.71% | 2 | May 14, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $0.44 | +2,172.73% | 1 | Apr 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $95 → $86 | $82.67 | +4.03% | 2 | Mar 23, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $35 → $44 | $16.52 | +166.34% | 2 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $182 → $166 | $20.34 | +716.13% | 1 | Jan 8, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 → $18 | $1.41 | +1,176.60% | 1 | May 5, 2020 |
Immunome
Dec 16, 2025
Maintains: Buy
Price Target: $22 → $32
Current: $24.62
Upside: +29.98%
OS Therapies
Nov 18, 2025
Maintains: Buy
Price Target: $18 → $17
Current: $1.36
Upside: +1,150.00%
Genelux
Oct 21, 2025
Initiates: Buy
Price Target: $16
Current: $2.66
Upside: +501.50%
Monopar Therapeutics
Sep 23, 2025
Initiates: Buy
Price Target: $106
Current: $60.38
Upside: +75.55%
Bolt Biotherapeutics
Aug 15, 2025
Maintains: Buy
Price Target: $4 → $75
Current: $5.90
Upside: +1,171.19%
Oncolytics Biotech
Aug 13, 2025
Initiates: Buy
Price Target: $7
Current: $0.98
Upside: +613.78%
Coya Therapeutics
Jul 9, 2025
Initiates: Buy
Price Target: $16
Current: $4.65
Upside: +244.09%
Lantern Pharma
Apr 2, 2025
Initiates: Buy
Price Target: $25
Current: $3.15
Upside: +693.65%
Esperion Therapeutics
Aug 3, 2021
Maintains: Strong Buy
Price Target: $134 → $114
Current: $3.39
Upside: +3,262.83%
Celcuity
Jul 27, 2021
Initiates: Buy
Price Target: $50
Current: $109.42
Upside: -54.30%
Jul 19, 2021
Maintains: Buy
Price Target: $33 → $48
Current: $63.19
Upside: -24.04%
Jun 28, 2021
Maintains: Buy
Price Target: $33 → $30
Current: $41.36
Upside: -27.47%
Jun 17, 2021
Initiates: Buy
Price Target: $50
Current: $72.57
Upside: -31.10%
May 14, 2021
Maintains: Buy
Price Target: $31 → $29
Current: $7.76
Upside: +273.71%
Apr 5, 2021
Initiates: Buy
Price Target: $10
Current: $0.44
Upside: +2,172.73%
Mar 23, 2021
Maintains: Buy
Price Target: $95 → $86
Current: $82.67
Upside: +4.03%
Jan 8, 2021
Maintains: Buy
Price Target: $35 → $44
Current: $16.52
Upside: +166.34%
Jan 8, 2021
Maintains: Buy
Price Target: $182 → $166
Current: $20.34
Upside: +716.13%
May 5, 2020
Maintains: Buy
Price Target: $15 → $18
Current: $1.41
Upside: +1,176.60%